Back to Trades
Buy4
Artiva Biotherapeutics, Inc.
ARTV
Total Value
$16.5M
Net $16.5M bought
Purchases
$16.5M
2 transactions
Company Information
- Company Name
- Artiva Biotherapeutics, Inc.
- Ticker Symbol
- ARTV
- CIK
- 0001817241
Insider Information
- Name
- GC Corp.
- Role
- Insider
Filing Details
- Filing Date
- May 28, 2026
- Transaction Date
- May 11, 2026
- Accession Number
- 0001931382-26-000007
- Form Type
- 4
- Net Trading Amount
- $16.5M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | 1,085,069 | $11.52 | Purchase | $12.5M |
| May 11, 2026 | Common Stock | 347,222 | $11.52 | Purchase | $4.0M |
Footnotes
- (F1)GC Corp., a public Korean holdings company, is ultimately controlled by its board of directors. As of March 26, 2026, the board consists of: Mr. Yong-Jun Huh, Huh Il-Sup, Park Yong-Tae, Kang Joonho, and Lee Choonwoo. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and each disclaims beneficial ownership of all shares held by GC Corp., except to the extent of any pecuniary interest therein.
- (F2)The shares are held directly by GC Cell Corporation. GC Corp., a public Korean holdings company, is the parent company of GC Cell Corporation and is ultimately controlled by its board of directors. As of March 26, 2026, the board consists of: Mr. Yong-Jun Huh, Huh Il-Sup, Park Yong-Tae, Kang Joonho, and Lee Choonwoo. Each of these individual directors of GC Corp. may be deemed to share voting and investment power over the shares held by GC Corp. and GC Cell Corporation and each disclaims beneficial ownership of all shares held by such entities, except to the extent of any pecuniary interest therein.